SavedAdd your journal

Journals / Nefroloji Hemşireliği Dergisi / 2022 / Cilt: 17 - Sayı: 1

The Risk of Hemorrhage and Nursing Care in Patients with Crimean-Congo Hemorrhagic Fever/ Kırım-Kongo Kanamalı Ateşi Tanılı Hastalarda Kanama Riski ve Hemşirelik Bakımı

Şengül KORKMAZ BİNAY
Aylin AKTAŞ ÖZAKGÜL
Pages
39–46
Publication Date
2022-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Crimean-Congo Hemorrhagic Fever; Hemorrhage; Nursing Care; Thrombocytopenia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thrombocytopenia is seen at a rate of 95-100% in patients diagnosed with Crimean-Congo Hemorrhagic Fever (CCHF).
📊
Key Findings & Data:The presence of poor prognosis factors causes the thrombocytopenia to rapidly deepen, and insufficient transfusion causes increased mortality rates.
💡
Conclusion & Impact:Keywords: Crimean-Congo Hemorrhagic Fever; Hemorrhage; Nursing Care; Thrombocytopenia.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kırım-Kongo Kanamalı Ateşi · kanama · hemşirelik bakımı

Abstract

Thrombocytopenia is seen at a rate of 95-100% in patients diagnosed with Crimean-Congo Hemorrhagic Fever (CCHF). Activation of the coagulation cascade with the effect of endothelial damage leads to thrombocytopenia, hemorrhage, disseminated intravascular coagulation, and multi-organ failure. The presence of poor prognosis factors causes the thrombocytopenia to rapidly deepen, and insufficient transfusion causes increased mortality rates. In patients with CCHF, independent nursing interventions include identification of hemorrhage/hemorrhage risk, determining the factors causing hemorrhage, and solving the hemorrhage risk problem. Hence, the nurses who work in the unit where CCHF patients are treated should identify the hemorrhage risk in detail, specify individualized nursing interventions, follow evidence-based practice and be in collaboration with other health staff. This review presents information about nursing care aiming at hemorrhage/ hemorrhage risk developing from thrombocytopenia in patients with CCHF. Keywords: Crimean-Congo Hemorrhagic Fever; Hemorrhage; Nursing Care; Thrombocytopenia.

Özet

Kırım-Kongo Kanamalı Ateşi (KKKA) tanılı hastalarda %95-100 oranında trombositopeni görülmektedir. Hastalarda gelişen endotel hasarının etkisiyle koagülasyon kaskadının aktifleşmesi, trombositopeniye, kanamaya, yaygın damar içi pıhtılaşmaya ve çoklu organ yetmezliği gelişmesine yol açmaktadır. Kötü prognostik faktörlerin olması, trombositopeninin hızlı bir şekilde derinleşmesi ve yeterli transfüzyonun yapılmaması, mortalite oranlarının artmasına neden olmaktadır. KKKA tanılı hastalarda kanama/kanama riskini tanılama, kanamaya neden olan faktörleri belirleme ve kanama riski sorununu çözme, bağımsız hemşirelik girişimlerini ifade eder. Bu nedenle KKKA tanısı ile tedavi gören hastaların olduğu ilgili ünitede çalışan hemşirelerin, her hastada kanama riskini ayrıntılı tanılamaları, bireye özgü hemşirelik girişimlerini belirlemeleri, bu konudaki kanıta dayalı uygulamaları takip etmeleri ve diğer sağlık ekibi üyeleri ile iş birliği içinde olmaları gerekir. Bu derlemede, KKKA tanılı hastalarda trombositopeni sonucunda gelişen kanama/kanama riskini belirlemeye ve önlemeye yönelik planlanan hemşirelik bakımı yer almaktadır. Anahtar Kelimeler: Kırım-Kongo Kanamalı Ateşi; Kanama; Hemşirelik Bakımı; Trombositopeni

🔖

Cite This Article

BİNAY, Ş. K., ÖZAKGÜL, A. A. (2022). The Risk of Hemorrhage and Nursing Care in Patients with Crimean-Congo Hemorrhagic Fever/ Kırım-Kongo Kanamalı Ateşi Tanılı Hastalarda Kanama Riski ve Hemşirelik Bakımı. Nefroloji Hemşireliği Dergisi, Cilt: 17 - Sayı: 1, 39–46. https://ajindex.com/articles/386903

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Crimean-Congo haemorrhagic fever [WHO website]. January 2013. Available at: https://www.who.int/news-room/factsheets/detail/crimean-congo-haemorrhagic-fever. Accessed February 27, 2021
  2. Introduction to Crimean-Congo Haemorrhagic Fever [WHO website]. December 2019. Available at: https://www.who.int/publications/i/item/introduction-to-crimean-congo-haemorrhaigc-fever. Accessed February 27, 2021
  3. Mertens M, Schmidt K, Ozkul A, Groschup, MH. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral research. 2013; 98(2): 248-260.
  4. Ince Y, Yasa C, Metin M, Sonmez M, Meram E, Benkli B, et al. Crimean-Congo hemorrhagic fever infections reported by ProMED. International Journal of Infectious Diseases. 2014; 26: 44-46.
  5. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. International Journal of Infectious Diseases. 2009; 13(3): 380-386. https://doi.org/10.1016/ j.ijid.2008.07.021 6. Sheikh AS, Sheikh AA, Sheikh NS, Asif M, Afridi F, Malik MT. Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience. International Journal of Infectious Diseases. 2005; 9(1): 37-42. https://doi.org/ 10.1016/j.ijid.2004.02.007 7. Bakir, M., Ugurlu, M., Dokuzoguz, B., Bodur, H., Tasyaran, M. A., Vahaboglu, H., et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. Journal of medical microbiology. 2005; 54(4): 385-389.
  6. Spengler JR, Bergeron É, Spiropoulou CF. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Current opinion in virology. 2019; 34: 70-78.
  7. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral research. 2013; 100(1): 159-189.
  8. Whitehouse CA. Crimean–Congo hemorrhagic fever. Antiviral research. 2004; 64(3): 145-160. https://doi.org/10.1016/ j.antiviral.2004.08.001 11. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Current opinion in infectious diseases. 2007; 20(5): 495-500.
  9. Diz-Küçükkaya R, Chen J, Ged